title: Sentinel lymph node detection with large human serum albumin colloid particles in breast cancer.
abstract: Detection of metastatic involvement of lymph nodes is essential for management and prognostic evaluation in breast cancer patients. The success of lymphatic mapping depends on identifying the sentinel lymph node(s) draining the primary tumour. However, when mapping is performed with a radiocolloidal agent, the number of hot lymph nodes varies with the agent and its size, among other factors. In this study, we evaluated prospectively the detection rate of sentinel lymph nodes in breast cancer when injecting large particles (100-600 nm) of human serum albumin colloids (Senti-Scint). In 128 consecutive breast cancer patients without palpable lymph nodes, pre-operative static lymphoscintigraphic mapping of the breast was performed after subcutaneous injection of 15 MBq of the radiocolloid. Lymphoscintigrahic results were compared with intra-operative surgical gamma detection probe and blue dye mapping data. Pre-operative lymphoscintigraphy and surgical gamma detection probe both correctly detected 203 sentinel lymph nodes in 122/128 patients (95%), while blue dye mapping showed only 183 sentinel lymph nodes in 82% of the patients. Only one or two sentinel lymph nodes were identified in each patient, which allowed the surgeon easily to find the sentinel lymph node(s) intra-operatively. In conclusion, lymphoscintigraphy with large particles of human serum albumin colloids is a helpful and reliable procedure for the surgical management of breast cancer.
authors.affiliation: Department of Nuclear Medicine and Ludwig Boltzmann Institute of Nuclear Medicine, Wilhelminenspital, Vienna, Austria. siroos.mirzaei@nuk.wil.magwien.gv.at
authors.forename: S
authors.initials: S
authors.lastname: Mirzaei
authors.forename: M
authors.initials: M
authors.lastname: Rodrigues
authors.forename: B
authors.initials: B
authors.lastname: Hoffmann
authors.forename: P
authors.initials: P
authors.lastname: Knoll
authors.forename: M
authors.initials: M
authors.lastname: Riegler-Keil
authors.forename: W
authors.initials: W
authors.lastname: Kreuzer
authors.forename: H
authors.initials: H
authors.lastname: Salzer
authors.forename: H
authors.initials: H
authors.lastname: Köhn
authors.forename: A
authors.initials: A
authors.lastname: Polyák
authors.forename: G A
authors.initials: GA
authors.lastname: Jánoki
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000473:pathology*; D002278:Carcinoma in Situ / Q000473:pathology; D044584:Carcinoma, Ductal / Q000473:pathology; D003102:Colloids / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D021701:Sentinel Lymph Node Biopsy / Q000379:methods*; D012709:Serum Albumin / Q000493:pharmacokinetics*
chemical_list: D003102:Colloids; D012709:Serum Albumin